Synergistic Effects of Ad-Libitum Low-Dose Fructose Drinking and Low-Dose Streptozotocin Treatment in Wistar Rats: A Mild Model of Type 2 Diabetes
To develop a convenient animal model of T2D by pretreatment with low-dose 10% w/v fructose (FRC) solution followed by the injection of low doses of streptozotocin (STZ) in Wistar rats. For this 8-week experimental study; rats were first fed a standard chow ad-libitum diet and either tap water (n=40) or 10% w/v FRC solution (n=40) for 4 weeks. Next, rats in each category were randomly allocated to 4 subgroups (n=10 each) of low-dose STZ (25,35, and 45 mg/kg). The final mean fasting blood sugar (FBG) of FRC+STZ45 (197±55.87 mg/dl) were significantly higher than that of the STZ45 (P=0.015) and FRC (P=0.019) groups. FRC+STZ45 showed the highest insulin resistance demonstrated by insulin tolerance test [area under the curve (AUC) of insulin tolerance test; P<0.05]. AUC was not significantly different between the STZ45 and non-STZ groups and between FRC and non-FRC fed groups. Furthermore, FBG levels did not differ between FRC and non-FRC groups. Body weight measurement showed that the FRC+STZ45 group had the lowest body weight compared to all other groups. Our data provide the evidence that FRC and STZ45 synergistically could induce hyperglycemia and insulin resistance in Wistar rats. Here we presented a feasible model for initial forms of T2D by employing pretreatment with low-dose FRC solution and treatment with low-dose STZ.
Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005; 52: 313-20.
Meshkani R and Adeli K. Mechanisms linking the metabolic syndrome and cardiovascular disease: role of hepatic insulin resistance. The Journal of Tehran University Heart Center. 2009; 4: 77-84.
Taheripak G, Bakhtiyari S, Rajabibazl M, Pasalar P and Meshkani R. Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells. Free radical biology & medicine. 2013; 65: 1435-46.
Wild S, Roglic G, Green A, Sicree R and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-53.
King AJ. The use of animal models in diabetes research. British journal of pharmacology. 2012; 166: 877-94.
Sasase T, Pezzolesi MG, Yokoi N, Yamada T and Matsumoto K. Animal Models of Diabetes and Metabolic Disease. Journal of Diabetes Research. 2013; 2013: 2.
Emamaullee JA, Merani S, Toso C, et al. Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. Endocrinology. 2009; 150: 2145-52.
Winzell MS and Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004; 53 Suppl 3: S215-9.
Ionut V, Liu H, Mooradian V, et al. Novel canine models of obese prediabetes and mild type 2 diabetes. American journal of physiology Endocrinology and metabolism. 2010; 298: E38-48.
Basciano H, Federico L and Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005; 2: 5.
Dekker MJ, Su Q, Baker C, Rutledge AC and Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. American journal of physiology Endocrinology and metabolism. 2010; 299: E685-94.
Hwang IS, Ho H, Hoffman BB and Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987; 10: 512-6.
Bell RC, Carlson JC, Storr KC, Herbert K and Sivak J. High-fructose feeding of streptozotocin-diabetic rats is associated with increased cataract formation and increased oxidative stress in the kidney. Br J Nutr. 2000; 84: 575-82.
de Moura RF, Ribeiro C, de Oliveira JA, Stevanato E and de Mello MA. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br J Nutr. 2009; 101: 1178-84.
Barros CM, Lessa RQ, Grechi MP, et al. Substitution of drinking water by fructose solution induces hyperinsulinemia and hyperglycemia in hamsters. Clinics (Sao Paulo). 2007; 62: 327-34.
Mahmoud MF, El-Nagar M and El-Bassossy HM. Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Archives of pharmacal research. 2012; 35: 155-62.
Anvari E, Keshtgar S, Noorafshan A and Rafati A. Induction of type 2 diabetes with high concentration and long term fructose intake in male Sprague-Dawley rats. Journal of Basic Research in Medical Sciences. 2014; 1: 42-50.
Wang J, Gao H, Ke D, et al. Improvement of Liquid Fructose-Induced Adipose Tissue Insulin Resistance by Ginger Treatment in Rats Is Associated with Suppression of Adipose Macrophage-Related Proinflammatory Cytokines. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: 12.
Messier C, Whately K, Liang J, Du L and Puissant D. The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behav Brain Res. 2007; 178: 139-45.
Sanchez-Lozada LG, Tapia E, Jimenez A, et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol. 2007; 292: F423-9.
Moraes-Silva IC, Mostarda C, Moreira ED, et al. Preventive role of exercise training in autonomic, hemodynamic, and metabolic parameters in rats under high risk of metabolic syndrome development. J Appl Physiol (1985). 2013; 114: 786-91.
Shafrir E. Contribution of animal models to the research of the causes of diabetes. World journal of diabetes. 2010; 1: 137.
Bonnevie-Nielsen V, Steffes MW and Lernmark A. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes. 1981; 30: 424-9.
Tran LT, Yuen VG and McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Molecular and cellular biochemistry. 2009; 332: 145-59.
DiNicolantonio JJ, O'Keefe JH and Lucan SC. Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clinic proceedings. 2015; 90: 372-81.
Rutledge AC and Adeli K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutrition reviews. 2007; 65: S13-23.